Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2003
10/02/2003WO2003081251A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003WO2003081250A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003WO2003080873A1 Cleaning animal skins
10/02/2003WO2003080856A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003WO2003080853A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003WO2003080850A1 Process for preparing conjugated linoleic acid
10/02/2003WO2003080843A1 Method for l-threonine production
10/02/2003WO2003080842A1 Zearalenone-detoxifying enzyme gene and transformant having the gene transferred thereinto
10/02/2003WO2003080836A1 Nerve regeneration genes
10/02/2003WO2003080835A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003WO2003080833A1 Xanthosine methylase and use thereof
10/02/2003WO2003080832A1 Candida utilis containing ϝ-glutamylcysteine
10/02/2003WO2003080830A1 Modified promoter
10/02/2003WO2003080826A1 Saccharomyces cerevisiae yeast strain with improved phytase activity
10/02/2003WO2003080814A1 Method of continuous culture of anaerobic bacterium
10/02/2003WO2003080813A2 Lactobacillus strains
10/02/2003WO2003080812A1 Novel white rot fungus and use thereof in wood pretreatment
10/02/2003WO2003080811A1 Denatured spirulina and manufacturing method thereof
10/02/2003WO2003080808A2 Novel compositions and methods in cancer
10/02/2003WO2003080668A1 NUCLEAR RECEPTOR RXRα ISOFORMS
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080639A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003WO2003080570A2 Recombinant expression vectors for functional nav1.9 sodium channels
10/02/2003WO2003079977A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003WO2003079792A1 Methods and compositions for vaccination against or involving enterobacteriaceae bacteria
10/02/2003WO2003079757A2 Hiv therapeutic
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003035694A3 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
10/02/2003WO2003033534A3 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof
10/02/2003WO2003031599A3 Live attenuated salmonella strains for producing vaccines
10/02/2003WO2003027274A3 Purified polypeptides from pseudomonas aeruginosa
10/02/2003WO2003016535A3 Novel amylases and uses thereof
10/02/2003WO2003016509A3 Resuscitation of not immediately culturable bacteria
10/02/2003WO2003010194A3 Meningococcus adhesins nada, app and orf 40
10/02/2003WO2003006665A8 Lawsonia intracellularis
10/02/2003WO2003006493A3 Histidine phosphatase interacting protein with 180kd
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002079473A3 Molecules for diagnostics and therapeutics
10/02/2003WO2002070737A9 Compositions and methods relating to osteoarthritis
10/02/2003WO2002068597A3 Enzymes having alpha amylase activity and methods of use thereof
10/02/2003WO2002061094A3 Microbiological method for producing l-carnitine
10/02/2003WO2002057474A3 Processes for enhanced production of pantothenate
10/02/2003WO2002022809A3 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
10/02/2003WO2002002623A3 Compositions and methods for the therapy and diagnosis of lung cancer
10/02/2003WO2001098491A3 Osteolevin gene polymorphisms
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003US20030188327 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/02/2003US20030187243 Novel expression-regulating sequences and expression products in the field of filamentous fungi
10/02/2003US20030187242 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187230 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187229 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187228 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187226 Process of high purity albumin production
10/02/2003US20030187224 Chimeric OPG polypeptides
10/02/2003US20030187200 Comprises nucleotide sequences coding kunitz-type protease inhibitor for treating reproductive, hemostatic and inflammatory disorders
10/02/2003US20030187197 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187196 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186899 Produced by culturing Saccharopolyspora species LW107129 (NRRL 30141); insecticidal and acaricidal activity; useful intermediates for preparing spinosyn analogs
10/02/2003US20030186880 Combination therapy using trefoil peptides
10/02/2003US20030186879 Nucleic acids that code for acylcoenzyme A; cholesterol acyltransferase (ACAT) required for viability protein (ARV1p), used to controlling lipid oil metabolism
10/02/2003US20030186852 Compositions and methods for controlling plant pests
10/02/2003US20030186851 Binding of a proteinaceous substance to cell-wall material of a Gram-positive bacterium
10/02/2003US20030186848 Recombinant iron uptake proteins
10/02/2003US20030186841 Ligand activated transcriptional regulator proteins
10/02/2003US20030186443 Phytase active yeast
10/02/2003US20030186430 Cell lysis device
10/02/2003US20030186425 Muscodor culture for use in generation of fungicidal, bactericidal, insecticidal and nematocidal compositions for biological pest control
10/02/2003US20030186423 Amidase from variovorax
10/02/2003US20030186422 Methods for the treatment of thrombosis
10/02/2003US20030186421 Comprises lipoprotein associated phospholipase A2 (Lp-PLA2) for diagnosing and treating atherosclerosis; enzyme inhibitors
10/02/2003US20030186420 Prolidase and its gene and method for producing prolidase
10/02/2003US20030186419 Masp-3, a complement-fixing enzyme, and uses for it
10/02/2003US20030186418 Novel variant EGIII-like cellulase compositions
10/02/2003US20030186416 Coding sequence for protein phosphatase methylesterase, recombinant DNA molecules and methods
10/02/2003US20030186412 Polypeptides which asymmetrically reduce N-benzyl-3-pyrrolidinone to produce (S)-N-benzyl-3-pyrrolidinol with NADPH as coenzyme
10/02/2003US20030186410 Comprises enzymatic protein which reduces phenylpyruvic acid and produces phenyllactic acid; hypotensive agents
10/02/2003US20030186408 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186407 Comprises membrane protein for use as antitumor/antiproliferative/antiinflammatory/anticarcinogenic agents
10/02/2003US20030186406 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
10/02/2003US20030186402 Engineering fungi for the utilisation of l-arabinose
10/02/2003US20030186400 Method for producing optically active 2-hydroxycycloalkanecarboxylic acid ester
10/02/2003US20030186399 Comprises aerobic cultivation of Dipldia gossypina, followed by isolation or esterification; for use in cigarettes, hair sprays
10/02/2003US20030186393 L-cysteine producing bacterium and method for producing L-cysteine
10/02/2003US20030186389 For degradation by fucoidan deacetylases, glucuronidases, and fucosidases
10/02/2003US20030186384 Comprises enzyme complex formed from proteases for modulating apoptosis and treating tumor, allergenic, autoimmune diseases and inflammatory diseases
10/02/2003US20030186383 Comprise nucleotide sequences coding growth factor polypeptide for diagnosing and treating autoimmune, cell proliferative, atherosclerotic, inflammatory and cancer disorders; tissue engineering; wound healing agents
10/02/2003US20030186381 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/02/2003US20030186380 Methods for producing secreted polypeptides having L-asparaginase activity
10/02/2003US20030186378 Useful mutations of bacterial alkaline protease
10/02/2003US20030186374 Multimeric polypeptide plasmid for expression of complex heterologous proteins
10/02/2003US20030186370 Comprises nucleotide sequences coding nicotinic-acetylcholine receptor (5-ht3) for use in screening nematocides, insecticides and/or pesticides
10/02/2003US20030186369 Egg specific surface proteins
10/02/2003US20030186364 For producing vaccines for the prevention or attenuation of infection by Staphylococcus
10/02/2003US20030186363 Method for cloning and expression of BsaI restriction endonuclease and BsaI methylase in E. coli
10/02/2003US20030186359 Genes encoding insect odorant receptors and uses thereof
10/02/2003US20030186354 Mutated penicillin expandase and process for preparing 7- ADCA using the same
10/02/2003US20030186342 Immunoenzymatic quantification method
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186333 Comprises nervous system polypeptide for diagnosis, prognosis, treatment and evaluation of neurodegenerative disorders
10/02/2003US20030186331 Process for preparing control samples of particles such as microorganisms and cells
1 ... 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 ... 1489